Company information:
Prof. Dr. Kaden & Kollegen Treuhand Ltd (No: 05377877)
Address: 124 CITY ROAD, LONDON, EC1V 2NX, UNITED KINGDOM
Status: Active
Incorporated: 28-Feb-2005
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 14-Mar-2025
Industry Class: 82990 - Other business support service activities n.e.c.
Current Director: MATTHIAS KIRCHNER ( DOB: Sep-1975 From: Sep-2019 )
Current Secretary: DR. SEITZ & KOLLEGEN SECRATARIES LTD ( From: Mar-2018 )
Resigned Director: RENE DE LA PORTE ( DOB: Jan-1959 From: Feb-2005 To: Nov-2005 )
Resigned Director: MICHAEL DOEGE ( From: Mar-2014 To: May-2014 )
Resigned Director: MICHAEL DOEGE ( From: Sep-2015 To: Sep-2015 )
Resigned Director: JOACHIM KIECKBUSCH ( DOB: May-1954 From: Mar-2018 To: Jan-2019 )
Resigned Director: MANFRED MARGRAF ( From: Sep-2015 To: Mar-2018 )
Resigned Director: MANFRED MARGRAF ( DOB: Feb-1953 From: May-2014 To: Sep-2015 )
Resigned Director: MANFRED MARGRAF ( DOB: Feb-1953 From: May-2014 To: Sep-2015 )
Resigned Director: ARMIN SEITZ ( DOB: Nov-1954 From: Dec-2006 To: Mar-2014 )
Resigned Secretary: B & B SECRETARIES LIMITED ( From: Feb-2005 To: Dec-2008 )
Resigned Secretary: DR. SEITZ & KOLLEGEN SECRETARIES LTD ( From: Jan-2009 To: Jan-2010 )
Resigned Secretary: MANFRED MARGRAF ( From: Apr-2014 To: Mar-2018 )
Persons of Significant Control:
Joachim Kieckbusch, Postfach 100262, C/O Dr.Seitz & Kollegen, Leipzig, D-04002, Germany: Has significant influence or control (Notified: 2018-03-07, Ceased: 2019-09-21)
Manfred Margraf, Postfach 100262, C/O Dr.Seitz & Kollegen, Leipzig, D-04002, Germany: Has significant influence or control (Notified: 2016-04-06, Ceased: 2018-03-08)
Matthias Kirchner, 100262 Postfach, C/O Dr. Seitz & Kollegen, Leipzig, D-04002, Germany: Has significant influence or control (Notified: 2019-09-19)
Company Accounts Summary (£)
Item | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Chart |
---|---|---|---|---|---|---|---|---|---|
Fixed assets | 1,000 | 1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0 | |||||||
Total assets less current liabilities | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0 |
Net assets (liabilities) | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0 |
Equity / share capital and reserves | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0 |